FILING ANALYSIS · TUESDAY, NOVEMBER 3
USANA HEALTH SCIENCES INC USNA — 8-K: Results of Operations and Financial Condition
neutral
USANA Health Sciences reported mixed Q3 results with net sales of $206 million, a net loss of $5.6 million, and adjusted diluted EPS of $0.11, while also updating fiscal 2026 guidance to net sales approaching $900 million and Adjusted EBITDA of $77 million. The company saw an 18% sequential increase in Hiya active monthly subscribers, but core nutritional active customers declined.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →